Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fauroux Brigitte, Khirani Sonia, Amaddeo Alessandro, Massenavette Bruno, Bierme Priscille, Taytard Jessica, Stremler Nathalie, Baravalle-Einaudi Melisande, Mazenq Julie, Ioan Iulia, Schweitzer Cyril, Lampin Marie Emilie, Binoche Alexandra, Mordacq Clemence, Bergounioux Jean, Mbieleu Blaise, Rubinsztajn Robert, Sigur Elodie, Labouret Geraldine, Genevois Aline, Becourt Arnaud, Hullo Eglantine, Pin Isabelle, Debelleix Stéphane, Galodé François, Bui Stéphanie, Moreau Johan, Renoux Marie Catherine, Matecki Stefan, Lavadera Marc Lubrano, Heyman Rachel, Pomedio Michael, Le Clainche Laurence, Bokov Plamen, Masson Alexandra, Hangard Pauline, Menetrey Celine, Jokic Mikael, Gachelin Elsa, Perisson Caroline, Pervillé Anne, Fina Agnes, Giovannini-Chami Lisa, Fleurence Emmanuelle, Barzic Audrey, Breining Audrey, Ollivier Morgane, Labbé Guillaume, Coutier Laurianne, Aubertin Guillaume
Аннотация
DESIGN: Cross-sectional national survey.
SETTING: Paediatric CPAP/NIV teams of 28 tertiary university hospitals in France.
PATIENTS: Children aged <20 years treated with CPAP/NIV since at least 3 months on June 1st, 2019.
INTERVENTION: An anonymous questionnaire was filled in for every patient.
RESULTS: The data of 1447 patients (60% boys), mean age 9.8 ± 5.8 years were analysed. The most frequent underlying disorders were: upper airway obstruction (46%), neuromuscular disease (28%), disorder of the central nervous system (13%), cardiorespiratory disorder (7%), and congenital bone disease (4%). Forty-five percent of the patients were treated with CPAP and 55% with NIV. Treatment was initiated electively for 92% of children, while 8% started during an acute illness. A poly(somno)graphy (P(S)G) was performed prior to treatment initiation in 26%, 36% had a P(S)G with transcutaneous carbon dioxide monitoring (PtcCO2), while 23% had only a pulse oximetry (SpO2) with PtcCO2 recording. The decision of CPAP/NIV initiation during an elective setting was based on the apnea-hypopnea index (AHI) in 41% of patients, SpO2 and PtcCO2 in 25% of patients, and AHI with PtcCO2 in 25% of patients. Objective adherence was excellent with a mean use of 7.6 ± 3.2 h/night. Duration of CPAP/NIV was 2.7 ± 2.9 years at the time of the survey.
CONCLUSION: This survey shows the large number of children treated with long term CPAP/NIV in France with numerous children having disorders other than neuromuscular diseases.